Advertisement
Organisation › Details
Takeda (Group)
Located in Osaka, Japan, Takeda is a research based global company with its main focus on pharmaceuticals. As the largest pharmaceutical company in Japan and one of the global leaders of the industry, Takeda is committed to striving toward better health for patients worldwide through leading innovation in medicine. *
Start | 1990-01-01 existent | |
Industry | pharmaceutical | |
Person | Weber, Christophe (Takeda 201504– CEO joined as COO 4/14 before GSK 201305 President GSK Vaccines) | |
Region | Osaka | |
Country | Japan | |
Street | 1-1 Doshomachi 4-chome Chuo-ku | |
City | 540-8645 Osaka | |
Tel | +81-6-6204-2111 | |
Address record changed: 2020-12-02 | ||
Basic data | Employees | H: 10,001 to 50,00 (2022-03-31) |
Currency | JPY | |
Annual sales | 3,569,006,000,000 (revenue, consolidated (21/22) 2022-03-31) | |
Profit | 230,059,000,000 (2022-03-31) | |
Cash | 849,695,000,000 (2022-03-31) | |
* Document for »About Section«: | ||
Record changed: 2024-08-24 |
Advertisement
More documents for Takeda (Group)
- [1] Tempus AI, Inc.. (9/26/24). "Press Release: Tempus Announces Expansion of Collaboration with Takeda to Leverage Multimodal Real-world Datasets and Biological Model Systems in Oncology Research and Development". Chicago, IL....
- [2] AC Immune S.A.. (5/13/24). "Press Release: AC Immune and Takeda Sign Exclusive Option and License Agreement for Active Immunotherapy Targeting Amyloid Beta for Alzheimer’s Disease". Osaka, Cambride, MA & Lausanne....
- [3] T-Curx GmbH. (8/28/23). "Press Release: T-Curx GmbH Announces Appointment of Two Industry Leaders to Its Board of Directors"....
- [4] Fresenius Medical Care AG & Co. KGaA. (12/5/22). "Press Release: Helen Giza to Take Over as Chief Executive Officer of Fresenius Medical Care"....
- [5] VectorY B.V.. (11/8/22). "Press Release: VectorY Appoints Sander van Deventer as CEO and Makes Key Appointments to Its Leadership Team". Amsterdam....
- [6] Heidelberg Pharma AG. (9/9/22). "Press Release: Heidelberg Pharma Announces Conclusion of License Agreement with Partner Takeda To Develop an Antibody Targeted Amanitin Conjugate". Ladenburg....
- [7] Takeda Pharmaceutical Co. Ltd.. (6/22/22). "Press Release: Takeda Announces Creation of One Cambridge Campus in Kendall Square to Drive Innovation Efforts". Cambridge, MA....
- [8] Takeda Pharmaceutical Co. Ltd.. (3/9/22). "Press Release: Takeda to Acquire Maverick Therapeutics to Advance T-Cell Engager Therapies for Solid Tumors and Expand Novel Immuno-Oncology Portfolio". Osaka & Brisbane, CA....
- [9] Takeda Pharmaceutical Co. Ltd.. (2/3/22). "Press Release: Takeda Announces Strategic Leadership Changes to Help Drive Continued Growth and Competitiveness in Global Marketplace". Osaka & Cambridge, MA....
- [10] Poseida Therapeutics, Inc.. (1/10/22). "Press Release: Poseida Therapeutics Announces Eric Ostertag to Serve as Executive Chairman and Transition Role of CEO to Current President and CBO Mark Gergen". San Diego, CA....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top